From companies working on coding automation to advances in cellular therapeutics, the top health systems across the country are investing in startups and established firms through their venture capital arms.
Here are some of the investments Cedars-Sinai Health Ventures, Mayo Clinic Ventures and Mass General Brigham Ventures made in 2022:
Cedars-Sinai Health (Los Angeles):
- Cedars-Sinai participated in a $46 million series B financing round for Fathom, a medical coding automation company.
- Vita Therapeutics, a company using cellular therapeutics to treat muscular dystrophy and cancer, received backing from Cedars-Sinai in a $31 million series B financing round.
- In July, Cedars-Sinai contributed to the $135 million financing round for diagnostics company Visby Medical.
- Cedars-Sinai participated in a $30 million funding round for Diligent Robotics, a service robot startup.
Mayo Clinic (Rochester, Minn):
- Mayo Clinic helped launch fertility company Turtle Health by participating in a $5.4 million financing round.
- The health system led a $1 million financing round for Patient Co., a company developing a patient moving tool.
- Mayo Clinic participated in a $7.3 million seed funding round Olive Diagnostics, a urinalysis company.
- Sendra Biosciences, a biotech company, received backing from Mayo Clinic in its $123 million series C financing round.
- In August, Mayo Clinic backed Diagnostic Robotics in a $45 million series B financing round.
Mass General Brigham (Boston):
- Mass General joined a $20 million series B financing round for clinical data company Carta Healthcare.
- The health system’s venture arm participated in a $26 million financing round for InStride Health, a virtual pediatric mental health company.
- In July, Mass General backed a $32 million seed funding round for Rippl, a mental health company focused on treating older adults.
- Mass General financed part of digital health company DexCare’s $50 million series B round.
